General Information of Drug (ID: DMC8UPL)

Drug Name
ION532 Drug Info
Synonyms AZD2373
Indication
Disease Entry ICD 11 Status REF
Chronic kidney disease GB61 Phase 1 [1]
Nephropathy GC2Z Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMC8UPL

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Apolipoprotein L1 messenger RNA (APOL1 mRNA) TTDB8PW APOL1_HUMAN Not Available [3]

References

1 ClinicalTrials.gov (NCT05351047) A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2373 Following Multiple Ascending Dose Administration to Healthy Male Participants of Sub-Saharan West African Ancestry. U.S.National Institutes of Health.
2 ClinicalTrials.gov (NCT04269031) A Phase I, First-in-Human, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2373 Following Single Ascending Dose Administrations to Healthy Male Subjects of African Ancestry. U.S.National Institutes of Health.
3 Clinical pipeline report, company report or official report of Ionis